(2023). Predicting the risk of acute kidney injury in primary care: derivation and validation of STRATIFY-AKI. Br J Gen Pract. http://doi.org/10.3399/bjgp.2022.0389.
Primary health care
(2023). Polypharmacy and antidepressant acceptability in comorbid depression and type 2 diabetes: a cohort study using UK primary care data. Br J Gen Pract, 73, e392-e398. http://doi.org/10.3399/bjgp.2022.0295.
(2022). Effect of competing mortality risks on predictive performance of the QFracture risk prediction tool for major osteoporotic fracture and hip fracture: external validation cohort study in a UK primary care population. Bmj Med, 1, e000316. http://doi.org/10.1136/bmjmed-2022-000316.
(2023). Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β(2)-Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England. Int J Chron Obstruct Pulmon Dis, 18, 231-245. http://doi.org/10.2147/copd.s389281.
(2023). Determining cardiovascular risk in patients with unattributed chest pain in UK primary care: an electronic health record study. Eur J Prev Cardiol. http://doi.org/10.1093/eurjpc/zwad055.
(2023). Prevalence of co-morbidity and history of recent infection in patients with neuromuscular disease: A cross-sectional analysis of United Kingdom primary care data. Plos One, 18, e0282513. http://doi.org/10.1371/journal.pone.0282513.
(2023). Socioeconomic gradient in mortality of working age and older adults with multiple long-term conditions in England and Ontario, Canada. Bmc Public Health, 23, 472. http://doi.org/10.1186/s12889-023-15370-y.
(2023). Sodium channel-inhibiting drugs and cancer-specific survival: a population-based study of electronic primary care data. Bmj Open, 13, e064376. http://doi.org/10.1136/bmjopen-2022-064376.
(2023). Combinations of medicines in patients with polypharmacy aged 65-100 in primary care: Large variability in risks of adverse drug related and emergency hospital admissions. Plos One, 18, e0281466. http://doi.org/10.1371/journal.pone.0281466.
(2023). Healthcare costs associated with short-acting β(2)-agonists in asthma: observational UK SABINA study. Bjgp Open. http://doi.org/10.3399/bjgpo.2023.0015.